Citations

Mayo Clinic

Showing 10 of 108585 citations.

A randomized double‐blind trial of clonidine and colesevelam for women with fecal incontinence
Varma, Revati , Feuerhak, Kelly, Mishra, Rahul , Chakraborty, Subhankar , Oblizajek, Nicholas R. , Bailey, Kent R. , Bharucha, Adil E. , Feuerhak, Kelly J, Oblizajek, Nicholas R

Neurogastroenterology & Motility | October 27, 2023 | Volume: 36 | Issue: 1 | Pages: No page available

10.1111/nmo.14697 | PMID 37890049 Get It

AbstractBackgroundDiarrhea and rectal urgency are risk factors for fecal incontinence (FI). The effectiveness of bowel modifiers for improving FI is unclear.MethodsIn this double‐blind, parallel‐group, randomized trial, women with urge FI were randomly assigned in a 1:1 ratio to a combination of oral clonidine (0.1 mg twice daily) with colesevelam (1875 mg twice daily) or two inert tablets for 4 weeks. The primary outcome was a ≥50% decrease in number of weekly FI episodes.Key ResultsFifty‐six participants were randomly assigned to clonidine–colesevelam (n = 24) or placebo (n = 32); 51 (91%) completed 4 weeks of treatment. At baseline, participants had a mean (SD) of 7.5 (8.2) FI episodes weekly. The primary outcome was met for 13 of 24 participants (54%) treated with clonidine–colesevelam versus 17 of 32 (53%) treated with placebo (p = 0.85). The Bristol stool form score decreased significantly, reflecting more formed stools with clonidine–colesevelam treatment (mean [SD], 4.5 [1.5] to 3.2 [1.5]; p = 0.02) but not with placebo (4.2 [1.9] to 4.1 [1.9]; p = 0.47). The proportion of FI episodes for semiformed stools decreased significantly from a mean (SD) of 76% (8%) to 61% (10%) in the clonidine–colesevelam group (p = 0.007) but not the placebo group (61% [8%] to 67% [8%]; p = 0.76). However, these treatment effects did not differ significantly between groups. Overall, clonidine–colesevelam was well tolerated.Conclusions and InferencesCompared with placebo, clonidine–colesevelam did not significantly improve FI despite being associated with more formed stools and fewer FI episodes for semiformed stools.
Wearable Real Time Location Services Technology for Staff Duress in Healthcare
Jones, Derick D. , Heaton, Heather A. , Wallerich, Timothy J., Riekmann, Laurie A., Handmacher, Bonnie H., Hatton, Ryan L.

2023 IEEE 13th International Conference on RFID Technology and Applications (RFID-TA) | October 27, 2023 | Volume: No volume available | Issue: No issue available | Pages: 127-129

10.1109/rfid-ta58140.2023.10290330 Get It

Rare Bipolaris Species Fungal Periprosthetic Hip Infection in an Immunocompetent Host
Tummala, Sailesh V. , Lin, Eugenia , Mujahed, Tala , Beauchamp, C.P. , Blair, Janis E. , Goulding, Krista , Beauchamp, Christopher P , Goulding, Krista A., Tummala, Sailesh V

JBJS Case Connector | October 27, 2023 | Volume: 13 | Issue: 4 | Pages: No page available

10.2106/jbjs.cc.23.00348 | PMID 37889989 Get It

Case: We present a case report of a 64-year-old man who developed a rare Bipolaris species fungal periprosthetic joint infection (PJI) after revision arthroplasty for complications associated with a metal-on-metal total hip arthroplasty. The patient underwent a 2-stage debridement with antibiotic bead placement and implant retention, along with chronic antifungal suppression. At the 2-year follow-up, the patient remained asymptomatic. Conclusion: Fungal PJI with filamentous fungi such as Bipolaris species is a rare clinical entity. This case report highlights the clinical presentation and management of this rare condition.
Perceptions Surrounding Cochlear Implants Among At-Risk and Qualifying Older Adults in the United States
Carlson, Matthew L. , Lohse, Christine M. , Marinelli, John P. , Sydlowski, Sarah, Collaborative, Hearing Health

Otology & Neurotology | October 27, 2023 | Volume: 44 | Issue: 10 | Pages: 1021-1026

10.1097/mao.0000000000004041 | PMID 37889933 Get It

Objective Limited evidence to date has examined public perceptions of cochlear implants among adult hearing aid users with moderate to profound hearing loss. The current work was conceived with the chief objective of characterizing the perceptions surrounding cochlear implants among the prospective candidate pool. Study design National cross-sectional survey study. Setting United States. Patients Adults between 50 and 80 years of age with self-reported moderate to moderately severe (n = 200) or moderately severe to profound (n = 200) hearing loss currently using hearing aids. Results The overall survey response rate was 12%. Median age at time of survey for the 400 respondents was 66 years (interquartile range, 60–71 yr) and included 215 (54%) men. In total, 26% did not think of hearing loss as a medical condition, and another 23% were unsure. Overall, 63% of respondents had heard of cochlear implants, but only 2% indicated they were very familiar with them. Despite 52% of respondents reporting “very positive” or “somewhat positive” feelings about cochlear implants, only 9% indicated they were “very likely” to get a cochlear implant in the future, including 7% of those with estimated moderately severe to profound hearing loss at time of survey. Conclusions Even among people with presumed qualifying levels of hearing loss, there exists a widespread lack of familiarity with cochlear implantation as a viable treatment option. This limited awareness seems influenced by a generally poor appreciation for hearing loss as a chronic disease state that warrants treatment. However, among those familiar with cochlear implants, they are generally viewed favorably.
Locked in from fulminant GBS after lumbar spine surgery
Hass, Reece, Wijdicks, Eelco F. M. , Wijdicks, Eelco Fm

Practical Neurology | October 27, 2023 | Volume: 24 | Issue: 1 | Pages: 63-65

10.1136/pn-2023-003925 | PMID 37890999 Get It

Guillain-Barré syndrome (GBS) describes a neurological syndrome characterised by acute, areflexic paralysis, often preceded by an immune stimulating event such as infection or surgery. Spinal surgery as an inciting event is very uncommon with few reported cases. When paraparesis develops in close proximity of surgery, surgical complications should be considered, but if an asymptomatic clinical interval precedes a progressive ascending weakness this association weakens and may support an immunological mechanism. GBS after lumbar surgery is wholly unexpected and thus there are significant challenges in recognising and making the diagnosis. We report a case of fulminant GBS that progressed to loss of all motor function following elective lumbar spine surgery.
Pharmacist Care for Reactive Airway Disease
Ghosh, Amit K.

JAMA | October 27, 2023 | Volume: 289 | Issue: 9 | Pages: 1104

10.1001/jama.289.9.1103-d Get It

Impact of obesity and overweight on C‐reactive protein concentrations and disease activity in rheumatoid arthritis: A systematic review and meta‐analysis
Flores-Alvarado, Diana Elsa , Esquivel‐Valerio, Jorge Antonio , Vega‐Morales, David , Garza-Cisneros, A. N. , Balderas-Palacios, M. A., Galarza-Delgado, D. Á. , García-Leal, Mariana , Galarza-Delgado, Dionicio Angel

International Journal of Rheumatic Diseases | October 27, 2023 | Volume: 26 | Issue: 12 | Pages: 2498-2508

10.1111/1756-185x.14948 | PMID 37888904 Get It

AbstractAimThis study aims to assess the association of obesity and CRP concentrations in adult patients with rheumatoid arthritis (RA), and its influence on measures of disease activity.MethodsA comprehensive search was performed using Scopus, Web of Science, MEDLINE, and EMBASE, from the time of their inception to November 2021. Observational studies that evaluated the association between CRP concentrations and obesity or overweight in patients with RA were considered eligible. Correlation coefficients were pooled using the inverse variance method, while effect sizes were pre‐calculated for adjusted standardized regression coefficients (β).ResultsA total of 10 studies, which comprised 4024 patients, were included in this systematic review. Individually, most studies report a significant association between CRP concentrations and a higher body mass index or other adiposity measures, but the statistical significance was not sustained when pooling their data together. Through the estimates provided in the present review, it is noted that CRP tends to be more elevated in female patients with RA that have a higher BMI. However, this association is not present in men.ConclusionCRP tends to be elevated in female patients with RA that have a higher BMI. Further research is required to assess this possible sex‐related difference and to aid shared decision‐making in order to avoid over‐treatment and increased burden in patients with obesity and RA.PROSPERO registration number: CRD42022314580.
Re-Evaluating Chemotherapy Dosing Strategies for Ovarian Cancer: Impact of Sarcopenia
Shah, Rushi , Polen-De, Clarissa , McGree, Michaela E. , Fought, Angela J. , Kumar, Amanika , McGree, Michaela, Fought, Angela, Kumar, Amanika

Current Oncology | October 27, 2023 | Volume: 30 | Issue: 11 | Pages: 9501-9513

10.3390/curroncol30110688 | PMID 37999108 Get It

We investigated the impact of sarcopenia on adjuvant chemotherapy dosing in advanced epithelial ovarian cancer (EOC). The chemotherapy dosing and toxicity of 173 eligible patients who underwent cytoreductive surgery and adjuvant chemotherapy at a single institution were analyzed. Patients with a skeletal muscle index less than 39 cm2/m2 measured on a CT scan were considered sarcopenic. Sarcopenic and non-sarcopenic patients were compared with regard to relative dose intensity (RDI), completion of scheduled chemotherapy, toxicity, and survival. A total of 62 (35.8%) women were sarcopenic. Sarcopenic women were less likely to complete at least six cycles of chemotherapy (83.9% vs. 95.5%, p = 0.02). The mean RDI for both carboplatin (80.4% vs. 89.4%, p = 0.03) and paclitaxel (91.9% vs. 104.1%, p = 0.03) was lower in sarcopenic patients compared to non-sarcopenic patients. Despite these differences in chemotherapy, there was no difference in neutropenia or median overall survival (3.99 vs. 4.57 years, p = 0.62) between the sarcopenic and non-sarcopenic women, respectively. This study highlights the importance of considering lean body mass instead of body weight or surface area in chemotherapy dosing formulas for sarcopenic women with advanced EOC. Further research is needed to optimize chemotherapy strategies based on individual body composition, potentially leading to improved dosing strategies in this population.
High‐risk adverse drug reactions: consideration of limited dialysis therapy for toxic epidermal necrolysis (TEN)
Xie, Guozhen , el‐Azhary, Rokea A. , Pincelli, T , El-Azhary, Rokea , Sokumbi, Olayemi , Pincelli, Thaís , Hickson, LaTonya J.

International Journal of Dermatology | October 27, 2023 | Volume: 63 | Issue: 1 | Pages: 5-9

10.1111/ijd.16882 | PMID 37888765 Get It

AbstractToxic epidermal necrolysis (TEN) is a rare but often lethal drug reaction involving the skin. Treatment is often centered around suppurative care, and the mortality rate remains unacceptably high, although the clinical and epidemiological features of TEN have been well documented for decades. Recent studies have placed an emphasis on certain medications in the pathophysiology of severe TEN, and our colleagues previously reported several cases of clinical improvement in TEN patients following hemodialysis. Here, we discuss the major considerations for initiating dialysis in TEN patients. By doing so, we hope to encourage others to explore this potential avenue for treating TEN, one of the most serious medical emergencies in the field of dermatology.
Artificial Intelligence-Based Prediction of Cardiovascular Diseases from Chest Radiography
Farina, Juan M. , Pereyra, Milagros , Mahmoud, Ahmed , Scalia, Isabel G. , Abbas, Mohammed Tiseer , Barry, Timothy , Ayoub, Chadi , Banerjee, Imon , Arsanjani, Reza , Barry, Timothy , Arsanjani, Reza , Banerjee, Imon , Farina, Juan M , Pereyra, Milagros , Mahmoud, Ahmed K , Scalia, Isabel G , Abbas, Mohammed Tiseer , Chao, Chieh‐Ju

Journal of Imaging | October 27, 2023 | Volume: 9 | Issue: 11 | Pages: 236

10.3390/jimaging9110236 | PMID 37998083 Get It

Chest radiography (CXR) is the most frequently performed radiological test worldwide because of its wide availability, non-invasive nature, and low cost. The ability of CXR to diagnose cardiovascular diseases, give insight into cardiac function, and predict cardiovascular events is often underutilized, not clearly understood, and affected by inter- and intra-observer variability. Therefore, more sophisticated tests are generally needed to assess cardiovascular diseases. Considering the sustained increase in the incidence of cardiovascular diseases, it is critical to find accessible, fast, and reproducible tests to help diagnose these frequent conditions. The expanded focus on the application of artificial intelligence (AI) with respect to diagnostic cardiovascular imaging has also been applied to CXR, with several publications suggesting that AI models can be trained to detect cardiovascular conditions by identifying features in the CXR. Multiple models have been developed to predict mortality, cardiovascular morphology and function, coronary artery disease, valvular heart diseases, aortic diseases, arrhythmias, pulmonary hypertension, and heart failure. The available evidence demonstrates that the use of AI-based tools applied to CXR for the diagnosis of cardiovascular conditions and prognostication has the potential to transform clinical care. AI-analyzed CXRs could be utilized in the future as a complimentary, easy-to-apply technology to improve diagnosis and risk stratification for cardiovascular diseases. Such advances will likely help better target more advanced investigations, which may reduce the burden of testing in some cases, as well as better identify higher-risk patients who would benefit from earlier, dedicated, and comprehensive cardiovascular evaluation.